USPTO serial 79302417
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Shanghai SynTheAll Pharmaceutical Co., Ltd.
CN
Other trademarks owned by Shanghai SynTheAll Pharmaceutical Co., Ltd.
Shanghai SynTheAll Pharmaceutical Co., Ltd.
CN
Other trademarks owned by Shanghai SynTheAll Pharmaceutical Co., Ltd.
Shanghai SynTheAll Pharmaceutical Co., Ltd.
CN
Other trademarks owned by Shanghai SynTheAll Pharmaceutical Co., Ltd.
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Alkaloids for industrial purposes; acids, namely boracic acid, carbonic acid; alkalies; protein in raw material form for scientific and medical research; chemical additives for insecticides; unprocessed artificial synthetic resins | ACTIVE | — |
| 005 | Medicines for human purposes, namely for the treatment of diabetes, sinus infection; bacteriological preparations for medical and veterinary use; raw material medicine, namely miconazole nitrate for use in the manufacture of medicines, namely anti-allergic medicines, and prescription and non-prescription medicines for the prevention and treatment of bacterial, dermatological and gynecological diseases; pharmaceutical preparations, namely for the treatment of dermatological and gastro-intestinal disease; chemical and pharmaceutical preparations, namely for the treatment of gynecological disease; biological preparations for medical purposes, namely for the treatment of cancer; chemical preparations for medical purposes, namely for the treatment of respiratory disease; chemical preparations for pharmaceutical purposes, namely iodine, bromine | ACTIVE | — |
| 040 | Processing and handling of chemical reagents, namely drying, filtering and grinding chemical reagents; processing of medicinal materials, namely custom manufacturing of prescription and non-prescription medicines for the prevention and treatment of dermatological and gastro-intestinal diseases | ACTIVE | — |
| 042 | Technical research in the field of pharmaceuticals; research and development for others in the field of medicine; chemical analysis; chemistry services, namely researching of production methods for manufacturing or transforming the substance in the laboratory and mass produced in factories; chemical research; biological research | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 17, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 1, 2022 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Sep 1, 2022 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Jul 19, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 8, 2022 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Apr 19, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 1, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 1, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 29, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 12, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 12, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 12, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 29, 2021 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 29, 2021 | ALIE | ASSIGNED TO LIE | — |
| Dec 27, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 1, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 30, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 30, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 27, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 1, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 1, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 29, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 28, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 28, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 23, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 19, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 14, 2021 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |